FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

ValueSets

83,706 resources

Source: Text:

By Version

By Authority

By Realm

 

Start Prev Rows 45200 - 45400 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmAuthSource(s)
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.43.jsonSGLT2 Ingredientsactive2022-07ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.44.jsonMRA Ingredientsactive2022-07ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.49.jsonMinnesota Living with Heart Failure Questionnaireactive2022-07ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.5.jsonHypothyroidismactive2024-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.50.jsonKansas City Cardiomyopathy Questionnaireactive2022-07ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.51.jsonCardiac Paceractive2021-11ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.52.jsonCardiac Paceractive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.53.jsonCardiac Paceractive2022-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.54.jsonHeart Transplant Complicationsactive2022-03ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.55.jsonHeart Transplant Complicationsactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.56.jsonHeart Transplant Complicationsactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.57.jsonLeft Ventricular Assist Device Complicationsactive2022-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.58.jsonLeft Ventricular Assist Device Complicationsactive2022-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.59.jsonLeft Ventricular Assist Device Placementactive2023-02ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.6.jsonHypothyroidismactive2021-04ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.60.jsonLeft Ventricular Assist Device Placementactive2023-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.61.jsonLeft Ventricular Assist Device Placementactive2022-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.62.jsonLeft Ventricular Assist Device Placementactive2022-02ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.63.jsonHeart Transplantactive2022-07ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.65.jsonCardiac Paceractive2022-11ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.66.jsonDiastolic Heart Failureactive2023-06ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.67.jsonDiastolic Heart Failureactive2023-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.68.jsonDiastolic Heart Failureactive2022-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.69.jsonAllergy to SGLT2 Inhibitorsactive2023-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.7.jsonAnorexia Nervosaactive2023-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.70.jsonIntolerance to SGLT2 Inhibitorsactive2022-07ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.71.jsonIntolerance to MRA Therapyactive2022-07ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.72.jsonARNI Ingredientactive2022-02ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.73.jsonMitral Stenosisactive2022-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.74.jsonMitral Stenosisactive2022-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.75.jsonMitral Stenosisactive2022-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.76.jsonMechanical Prosthetic Heart Valveactive2022-11ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.77.jsonMechanical Prosthetic Heart Valveactive2025-04ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.78.jsonMechanical Prosthetic Heart Valveactive2022-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.79.jsonMechanical Prosthetic Heart Valve in Situactive2022-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.8.jsonAnorexia Nervosaactive2021-04ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.82.jsonSystolic Heart Failureactive2023-03ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.83.jsonSystolic Heart Failureactive2023-03ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.84.jsonSystolic Heart Failureactive2023-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.85.jsonCarotid Interventionactive2023-03ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.86.jsonSerum Creatinineactive2023-10ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.87.jsonUrine Creatinineactive2025-03ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.88.jsonUrine Albuminactive2023-10ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.9.jsonAnorexia Nervosaactive2021-04ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.90.jsonNon Steroidal Mineralcorticoid Receptor Antagonistactive2024-10ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.91.jsonGlucagon like peptide 1 medicationsactive2024-11ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1178.96.jsonAHA GWTG Long COVID19active2024-10ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.1.jsonWound internal item and/or body structure visible value set (foundation metadata concept)active2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.11.jsonWound exudate appearance value set (foundation metadata concept)active2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.12.jsonWound exudate color value set (foundation metadata concept)active2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.13.jsonExudate odor value set (foundation metadata concept)active2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.16.jsonSkin temperature value set (foundation metadata concept)active2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.17.jsonSkin color enumerated value set (foundation metadata concept)active2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.18.jsonSkin turgor value set (foundation metadata concept)active2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.19.jsonSkin and mucous membrane integrity value set (foundation metadata concept)active2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.2.jsonPeriwound condition value set (foundation metadata concept)active2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.20.jsonSkin moisture value set (foundation metadata concept)active2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.3.jsonWound Type Etiology value setactive2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.4.jsonWound episode value set (foundation metadata concept)active2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.6.jsonWound bed appearance value set (foundation metadata concept)active2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.60.jsonWound type reference setactive2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.7.jsonWound bed color value set (foundation metadata concept)active2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.74.jsonNonverbal pain indicators reference setactive2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.76.jsonPain associated signs and symptoms reference setactive2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.77.jsonPain body location reference setactive2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.8.jsonWound edge description value set (foundation metadata concept)active2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.80.jsonPain quality reference setactive2025-03ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.81.jsonPain speed of onset reference setactive2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1181.9.jsonPresence absence value set (foundation metadata concept)active2018-07ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1186.1.jsonCommon drug substances for allergy and intolerance documentationactive2024-06ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1186.2.jsonCommon drug classes for allergy and intolerance documentationactive2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1186.3.jsonCommon dietary substances for allergy and intolerance documentationactive2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1186.4.jsonCommon environmental substances for allergy and intolerance documentationactive2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.10.jsonNHSNCriterionOfDiagnosisCode(CDCNHSN)active2020-08ushl7cdc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.11.jsonNHSNCriterionOfDiagnosisCode(SNOMEDCT)active2020-08ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.12.jsonNHSNInfectionConditionCode(CDCNHSN)active2020-08ushl7cdc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.13.jsonNHSNInfectionConditionCode(SNOMEDCT)active2020-08ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.14.jsonNHSNInfectionTypeCode(CDCNHSN)active2020-08ushl7cdc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.15.jsonNHSNInfectionTypeCode(SNOMEDCT)active2020-08ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.16.jsonNHSNInfectionFirstReportedSource(CDCNHSN)active2020-08ushl7cdc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.17.jsonNHSNInfectionFirstReportedSource(SNOMEDCT)active2020-08ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.18.jsonNHSNLOS/MENDischargeDisposition(CDCNHSN)active2020-08ushl7cdc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.19.jsonNHSNLOS/MENDischargeDisposition(SNOMEDCT)active2020-08ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.20.jsonNHSNPopulationSummaryReportTypeCode(CDCNHSN)active2020-08ushl7cdc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.21.jsonNHSNPopulationSummaryReportTypeCode(LOINC)active2020-08ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.22.jsonNHSNSameDayOutcomeMeasure(CDCNHSN)active2020-08ushl7cdc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.23.jsonNHSNSameDayOutcomeMeasure(SNOMEDCT)active2020-08ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.24.jsonNHSNSignificantPathogenCode(CDCNHSN)active2020-08ushl7cdc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.25.jsonNHSNSignificantPathogenCode(SNOMEDCT)active2020-08ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.26.jsonNHSNSpinalFusionApproachCode(CDCNHSN)active2020-08ushl7cdc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.27.jsonNHSNSpinalFusionApproachCode(SNOMEDCT)active2020-08ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.28.jsonNHSNVascularAccessTypeCode(CDCNHSN)active2020-08ushl7cdc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.29.jsonNHSNVascularAccessTypeCode(SNOMEDCT)active2020-08ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.30.jsonNHSNVascularSpecimenCollectionSite(CDCNHSN)active2020-08ushl7cdc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.31.jsonNHSNVascularSpecimenCollectionSite(SNOMEDCT)active2020-08ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.38.jsonBlood Glucose Laboratory and Point of Care Testsactive2023-09ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.6.jsonNHSNPathogenCodeAROactive2025-03ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.63.jsonBacterial and Fungal Blood Culture Testsactive2022-07ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.7.jsonNHSNRoleOfPerformerCode(CDCNHSN)active2020-08ushl7cdc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.74.jsonEnteral Medication Routeactive2022-07ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.75.jsonIntravenous Medication Routeactive2022-07ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.79.jsonFidaxomicin, Vancomycin, and Metronidazoleactive2022-07ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.8.jsonNHSNRoleOfPerformerCode(SNOMEDCT)active2020-08ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.85.jsonBaloxaviractive2023-05ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.86.jsonPeramiviractive2023-05ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.87.jsonZanamiviractive2023-05ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.88.jsonDigestive, Intramuscular, Intravenous Route of Administrationactive2023-10ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.9.jsonNHSNRoleOfPerformerCode(HealthCareProviderTaxonomy)active2020-08ushl7nucc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.90.jsonNHSN LTC AU Antimicrobial Agentsactive2024-05ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.91.jsonLong Term Care Discharge Dispositionactive2024-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.94.jsonNHSNNeurogenicBladderactive2025-03ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1190.95.jsonNHSNSpinalCordInjuryactive2025-03ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.147.jsonSCIP Major Surgical Procedureactive2019-06ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.3483.jsonFinancial Insecurity Screening Assessments Questionsactive2023-07ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.3484.jsonFood Insecurity Screening Assessments Questionsactive2023-07ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.3485.jsonHealth Literacy Screening Assessments Questionsactive2024-12ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.3486.jsonHomelessness Screening Assessments Questionsactive2023-08ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.3487.jsonHousing Instability Screening Assessments Questionsactive2023-08ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.3488.jsonLess Than High School Education Screening Assessments Questionsactive2023-07ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.3519.jsonHealth Insurance Coverage Status Screening Assessments And Questionsactive2023-07ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.3520.jsonInadequate Housing Screening Assessments And Questionsactive2023-07ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.393.jsonHypoglycemics Severe Hypoglycemiaactive2024-01ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.394.jsonHypoglycemics Treatment Medicationsactive2025-02ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.4448.jsonLidocaineactive2024-05ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.491.jsonMedium Dose ICS Formoterol Preparationsactive2021-09ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.495.jsonICS LABA LAMA Preparationsactive2021-09ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.788.jsonSocial Determinants of Health Conditionsactive2024-12ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.15.jsonGeneral Surgeryactive2020-04ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.17.jsonCoagulation Disorder Conditionsactive2020-04ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.19.jsonAnticoagulant Medicationsactive2025-02ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.20.jsonAnticoagulant Medications, Oralactive2024-03ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.21.jsonAnticoagulant Medications, Injectionactive2024-03ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.28.jsonActive Bleedingactive2020-11ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.29.jsonFall Risk Increasing Drugs (FRIDs)active2021-07ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.30.jsonFall Risk Factorsactive2021-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.32.jsonTotal Hip Arthroplasty Surgeryactive2021-03ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.33.jsonTotal Knee Arthroplasty Surgeryactive2021-03ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.46.jsonOpioid Medicationsactive2021-07ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.47.jsonImaging Related to VTEactive2023-01ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.48.jsonAnticoagulant Medicationactive2024-03ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.49.jsonVTE Diagnosesactive2025-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.50.jsonBisphosphonate Therapyactive2022-02ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.51.jsonVTE Symptomsactive2022-03ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.52.jsonOncology Critical Care Unitsactive2022-03ushl7cdc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.53.jsonProvider Typesactive2022-05ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.56.jsonFOBT_Labactive2024-07ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.58.jsonScreening Mammogram (CPT)active2024-08ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.59.jsonScreening Mammogram (LOINC)active2024-09ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.60.jsonScreening Mammogram (SNOMEDCT)active2024-08ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.61.jsonScreening Mammogram (Grouping)active2024-08ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.62.jsonDiagnostic Mammography (CPT)active2024-08ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.63.jsonDiagnostic Mammography (LOINC)active2024-09ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.64.jsonDiagnostic Mammography (SNOMEDCT)active2024-08ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.65.jsonDiagnostic Mammographyactive2024-08ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.66.jsonBreast Cancer Biopsy and Surgical Excisionactive2024-10ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.67.jsonBI_RADS Categories 0, 4, and 5active2024-10ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1206.68.jsonBI_RADS Categories 1, 2, and 3active2024-10ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1213.101.jsonLocal Anestheticsactive2023-07ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1213.102.jsonOphthalmic Epinephrinesactive2023-07ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1213.103.jsonInhaled Epinephrinesactive2023-07ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1213.104.jsonClopidogrelsactive2023-10ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1213.105.jsonCytochrome P450 2C19 inhibitorsactive2023-10ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1213.107.jsonAspirin Ingredient and Risk of GI Bleedingactive2023-12ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1213.109.jsonOral Anticoagulant Ingredients and Risk of GI Bleedingactive2023-12ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1213.112.jsonPPI and Risk of GI Bleedingactive2023-12ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1213.113.jsonAntiplatelet Ingredients and Risk of GI Bleedingactive2023-12ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1213.115.jsonKratom containing compoundsactive2024-07ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1213.117.jsonClopidogrel Ingredients and Risk of GI Bleedingactive2024-09ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1213.121.jsonGastrointestinal bleeding episode and Risk of GI Bleeding 1active2024-10ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1213.122.jsonGastrointestinal bleeding episode and Risk of GI Bleeding 2active2024-09ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1213.123.jsonGastrointestinal bleeding episode and Risk of GI Bleedingactive2024-09ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1213.24.jsonOxycodonesactive2024-07ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1219.1.jsonBronchiectasis Disorder SNOMEDactive2020-04ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1219.10.jsonInterstitial Lung Disease ICD10CMactive2022-03ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1219.100.jsonOccupational Therapy Procedure HCPCSactive2022-03ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1219.101.jsonOccupational Therapy Procedureactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1219.102.jsonSpeech Language Therapy Procedure HCPCSactive2022-03ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1219.103.jsonSpeech Language Therapy Procedureactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1219.104.jsonHome Health Procedureactive2022-03ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1219.105.jsonIntermittent Skilled Nursing Home Health Procedureactive2022-03ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1219.106.jsonpH, Hematocrit, Partial Pressure Carbon Dioxide, Partial Pressure Oxygen or Bicarbonate Laboratory Test for Breathing Assistance Device Evaluation Excluding Oxygen Saturationactive2022-03ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1219.107.jsonBreathing Test Procedure During Sleepactive2022-03ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1219.108.jsonAmbulance Transport Procedureactive2022-03ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1219.109.jsonPrefabricated Spinal Orthotic Deviceactive2022-03ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1219.11.jsonInterstitial Lung Disease SNOMEDCTactive2022-03ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1219.110.jsonCustom Fitted Spinal Orthotic Deviceactive2022-03ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1219.111.jsonCustom Fabricated Spinal Orthotic Deviceactive2022-03ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1219.112.jsonOrthotic Device Supplyactive2022-03ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1219.113.jsonSpinal Orthotic Device or Supplyactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1219.115.jsonSpine or Neck Disorder SNOMED CTactive2022-03ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1219.116.jsonSpine or Neck Disorder ICD10CMactive2022-03ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1219.117.jsonSpine or Neck Disorderactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1219.118.jsonTotal Electric Hospital Bed Supplyactive2022-03ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1219.119.jsonHypoventilation Disorder SNOMEDCTactive2022-03ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1219.12.jsonInterstitial Lung Diseaseactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1219.120.jsonHypoventilation Disorder ICD10CMactive2022-03ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1219.121.jsonHypoventilation Disorderactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1219.122.jsonRespiratory Assist Device Qualifying Conditionactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1219.123.jsonApnea Hypopnea Index Rate Measurementactive2022-03ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1219.124.jsonForced Expiratory Volume in One Second (FEV1)/Forced Vital Capacity (FVC) Measurementactive2022-03ushl7loinc